Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer

Purpose: We sought to examine the prognostic value of fluorodeoxyglucose-positron emission tomography (PET) imaging during chemoradiation for unresectable non-small cell lung cancer for survival and hypothesized that tumor PET response is correlated with peripheral T-cell function. Methods and Mater...

Full description

Bibliographic Details
Main Authors: Stephen R. Bowen, PhD, Daniel S. Hippe, MS, Hannah M. Thomas, PhD, Balukrishna Sasidharan, MBBS, MD, DNB, DMRT, Paul D. Lampe, PhD, Christina S. Baik, MD, MPH, Keith D. Eaton, MD, PhD, Sylvia Lee, MD, Renato G. Martins, MD, MPH, Rafael Santana-Davila, MD, Delphine L. Chen, MD, Paul E. Kinahan, PhD, Robert S. Miyaoka, PhD, Hubert J. Vesselle, MD, PhD, A. McGarry Houghton, MD, Ramesh Rengan, MD, PhD, Jing Zeng, MD
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109421002153

Similar Items